PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 60.10
+1.10 (1.86%)
Aug 26, 2026, 1:30 PM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 8.48 billion as of August 25, 2026. Its market cap has decreased by -14.24% in one year.
Market Cap
8.48B
Enterprise Value
3.44B
Revenue
1.03B
Ranking
n/a
PE Ratio
15.78
Stock Price
60.10
ChartMarket Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 8.48B, an increase of 57.60%. That is a compound annual growth rate of 3.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 8.48B | -16.19% |
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 9.97B |
| AP Biosciences | 9.84B |
| Tanvex BioPharma | 9.63B |
| TCM Biotech International | 9.27B |
| Locus Cell | 7.74B |
| Adimmune | 7.50B |
| Acepodia | 7.08B |
| Savior Lifetec | 6.76B |